Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In vitro activity of ceftolozane/tazobactam against Gram-negative isolates collected from ICU patients with lower respiratory tract infections in seven Asian countries-SMART 2017-2019.
Lob SH, Kazmierczak KM, Chen WT, Siddiqui F, DeRyke CA, Young K, Motyl MR, Sahm DF. Lob SH, et al. Among authors: kazmierczak km. J Glob Antimicrob Resist. 2022 Jun;29:527-533. doi: 10.1016/j.jgar.2021.11.011. Epub 2021 Dec 8. J Glob Antimicrob Resist. 2022. PMID: 34896336 Free article.
In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017-2019.
Karlowsky JA, Kazmierczak KM, Valente MLNF, Luengas EL, Baudrit M, Quintana A, Irani P, Stone GG, Sahm DF. Karlowsky JA, et al. Among authors: kazmierczak km. Braz J Infect Dis. 2021 Nov-Dec;25(6):101647. doi: 10.1016/j.bjid.2021.101647. Epub 2021 Nov 10. Braz J Infect Dis. 2021. PMID: 34774471 Free PMC article.
Ceftolozane/Tazobactam and Imipenem/Relebactam Cross-Susceptibility Among Clinical Isolates of Pseudomonas aeruginosa From Patients With Respiratory Tract Infections in ICU and Non-ICU Wards-SMART United States 2017-2019.
Lob SH, DePestel DD, DeRyke CA, Kazmierczak KM, Young K, Motyl MR, Sahm DF. Lob SH, et al. Among authors: kazmierczak km. Open Forum Infect Dis. 2021 Jun 16;8(7):ofab320. doi: 10.1093/ofid/ofab320. eCollection 2021 Jul. Open Forum Infect Dis. 2021. PMID: 34307727 Free PMC article.
57 results